Skip to main content
SpringerLink
Log in

Chemoprevention of Skin Cancer: Current Status and Future Prospects

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Chemoprevention represents a relatively new and promising strategy whereby the use of natural or synthetic agents the process of carcinogenesis can be slowed, reversed or completely halted. Especially for the skin cancer, chemoprevention could be an important armamentarium because of increasing incidence of such cancers and because skin is continuously exposed to various environmental carcinogens that include both chemical agents and solar ultraviolet radiations. A wide range of compounds, both synthetic and naturally occurring has been shown to possess cancer chemopreventive effects in murine skin carcinogenesis models. Only a limited number of these agents have been tested for their efficacy in the human population. Here, we provide a brief review on the skin cancer chemopreventive potential and mechanism of action of various synthetic and natural agents. Many of these agents are present in daily diet and are supplemented or topically applied against prevention of various stages of skin cancer. We will also discuss the current status and future prospects of these agents for development as promising chemopreventive agents against skin cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics. CA Cancer J Clin 51: 15–36, 2001

    Google Scholar 

  2. Gupta S, Mukhtar H: Chemoprevention of skin cancer through natural agents. Skin Pharmacol Appl Skin Physiol 14: 373–385, 2001

    Google Scholar 

  3. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr: Cancer statistics by race and ethnicity. CA Cancer J Clin 48: 31–48, 1998

    Google Scholar 

  4. Limmer BL: Nonmelanoma skin cancer:Today's epidemic. Tex Med 97: 56–58, 2001

    Google Scholar 

  5. Alam M, Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 344: 975–983, 2001

    Google Scholar 

  6. Heaphy MR Jr, Ackerman AB: The nature of solar keratosis: A critical review in historical perspective. J Am Acad Dermatol 43: 138–150, 2000

    Google Scholar 

  7. Jemal A, Devesa SS, Hartge P, Tucker MA: Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93: 678–683, 2001

    Google Scholar 

  8. Dal Maso L, Serraino D, Franceschi S: Epidemiology of HIV-associated malignancies. Cancer Treat Res 104: 1–18, 2001

    Google Scholar 

  9. Zackheim HS, Vonderheid EC, Ramsay DL, LeBoit PE, Rothfleisch J, Kashani-Sabet M: Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 43: 793–796, 2000

    Google Scholar 

  10. Green A, Whiteman D, Frost C, Battistutta D: Sun exposure, skin cancers and related skin conditions. J Epidemiol 9: S7–S13, 1999

    Google Scholar 

  11. Gallagher RP, Bajdik CD, Fincham S, Hill GB, Keefe AR, Coldman A, McLean DI: Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 5: 419–424, 1996

    Google Scholar 

  12. Yuspa SH, Dlugosz AA, Denning MF, Glick AB: Multistage carcinogenesis in the skin. J Investig Dermatol Symp Proc 1: 147–150, 1996

    Google Scholar 

  13. Agarwal R, Mukhtar H: Chemoprevention of photocarcinogenesis. Photochem Photobiol 63: 440–444, 1996

    Google Scholar 

  14. Rockley PF, Trieff N, Wagner RF Jr, Tyring SK: Nonsunlight risk factors for malignant melanoma. Part I: Chemical agents, physical conditions, and occupation. Int J Dermatol 33: 398–406, 1994

    Google Scholar 

  15. de Gruijl FR: Photocarcinogenesis: UVA vs. UVB. Methods Enzymol 319: 359–366, 2000

    Google Scholar 

  16. Yamaguchi N, Kinjo Y, Akiba S, Watanabe S: Ultraviolet radiation and health: From hazard identification to effective prevention. J Epidemiol 9: S1–S4, 1999

    Google Scholar 

  17. Soter NA: Acute effects of ultraviolet radiation on the skin. Semin Dermatol 9: 11–15, 1990

    Google Scholar 

  18. Wenk J, Brenneisen P, Meewes C, Wlaschek M, Peters T, Blaudschun R, Ma W, Kuhr L, Schneider L, Scharffetter-Kochanek K: UV-induced oxidative stress and photoaging. Curr Probl Dermatol 29: 83–94, 2001

    Google Scholar 

  19. Iwai I, Hatao M, Naganuma M, Kumano Y, Ichihashi M: UVA-induced immune suppression through an oxidative pathway. J Invest Dermatol 112: 19–24, 1999

    Google Scholar 

  20. Krutmann J, Grewe M: Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Invest Dermatol 105: 67S–70S, 1995

    Google Scholar 

  21. Drouin R, Therrien JP: UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53. Photochem Photobiol 66: 719–726, 1997

    Google Scholar 

  22. de Gruijl FR: Skin cancer and solar UV radiation. Eur J Cancer 35: 2003–2009, 1999

    Google Scholar 

  23. Grether-Beck S, Buettner R, Krutmann J: Ultraviolet A radiation-induced expression of human genes: Molecular and photobiological mechanisms. Biol Chem 378: 1231–1236, 1997

    Google Scholar 

  24. Kvam E, Tyrrell RM: Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis 18: 2379–2384, 1997

    Google Scholar 

  25. Scharffetter-Kochanek K, Wlaschek M, Brenneisen P, Schauen M, Blaudschun R, Wenk J: UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol Chem 378: 1247–1257, 1997

    Google Scholar 

  26. Pugliese PT: The skin's antioxidant systems. Dermatol Nurs 10: 401–416, 1998

    Google Scholar 

  27. Allen RG, Tresini M: Oxidative stress and gene regulation. Free Radic Biol Med 28: 463–499, 2000

    Google Scholar 

  28. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 408: 239–247, 2000

    Google Scholar 

  29. Ananthaswamy HN, Kanjilal S: Oncogenes and tumor suppressor genes in photocarcinogenesis. Photochem Photobiol 63: 428–432, 1996

    Google Scholar 

  30. Mukhtar H, Agarwal R: Skin cancer chemoprevention. J Investig Dermatol Symp Proc 1: 209–224, 1996

    Google Scholar 

  31. Kelloff GJ, Sigman CC, Greenwald P: Cancer chemoprevention: Progress and promise. Eur J Cancer 35: 2031–2038, 1999

    Google Scholar 

  32. Bickers DR, Athar M: Novel approaches to chemoprevention of skin cancer. J Dermatol 27: 691–695, 2000

    Google Scholar 

  33. Safe S, Wargovich MJ, Lamartiniere CA, Mukhtar H: Symposium on mechanisms of action of naturally occurring anticarcinogens. Toxicol Sci 52: 1–8, 1999

    Google Scholar 

  34. Lamson DW, Brignall MS: Natural agents in the prevention of cancer, part two: Preclinical data and chemoprevention for common cancers. Altern Med Rev 6: 167–187, 2001

    Google Scholar 

  35. Ley RD, Reeve VE: Chemoprevention of ultraviolet radiation-induced skin cancer. Environ Health Perspect 105: 981–984, 1997

    Google Scholar 

  36. Singh DK, Lippman SM: Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. Oncology 12: 1787–1800, 1998

    Google Scholar 

  37. Singh DK, Lippman SM: Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Oncology 12: 1643–1653, 1998

    Google Scholar 

  38. Katiyar SK, Ahmad N, Mukhtar H: Green tea and skin. Arch Dermatol 136: 989–994, 2000

    Google Scholar 

  39. Wolf R, Wolf D, Morganti P, Ruocco V: Sunscreens. Clin Dermatol 19: 452–459, 2001

    Google Scholar 

  40. Gasparro FP: Sunscreens, skin photobiology, and skin cancer: The need for UVA protection and evaluation of efficacy. Environ Health Perspect 1: 71–78, 2000

    Google Scholar 

  41. Heenen M: Photoprotection, cancer protection and solar protection factor. Rev Med Brux 20: 143–146, 1999

    Google Scholar 

  42. Green A: Chemoprevention of skin cancer. IARC Sci Publ 136: 111–119, 1996

    Google Scholar 

  43. Elmets CA, Anderson CY: Sunscreens and photocarcinogenesis: An objective assessment. Photochem Photobiol 63: 435–440, 1996

    Google Scholar 

  44. Gasparro FP, Mitchnick M, Nash JF: A review of sunscreen safety and efficacy. Photochem Photobiol 68: 243–256, 1998

    Google Scholar 

  45. Burke KE: The value of sunscreens. Int J Dermatol 38: 88–90, 1999

    Google Scholar 

  46. Diffey BL, Tanner PR, Matts PJ, Nash JF: In vitro assessment of the broad-spectrum ultraviolet protection of sunscreen products. J Am Acad Dermatol 43: 1024–1035, 2000

    Google Scholar 

  47. Cole C: Sunscreen protection in the ultraviolet A region: How to measure the effectiveness. Photodermatol Photoimmunol Photomed 17: 2–10, 2001

    Google Scholar 

  48. Pathak MA: Sunscreens: Progress and perspectives on photoprotection of human skin against UVB and UVA radiation. J Dermatol 23: 783–800, 1996

    Google Scholar 

  49. Niles RM: Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 16: 1084–1089, 2000

    Google Scholar 

  50. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ, De Luca LM: Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 21: 1271–1279, 2000

    Google Scholar 

  51. Kanekura T, Higashi Y, Kanzaki T: Inhibitory effects of 9-cis-retinoic acid and pyrrolidinedithiocarbamate on cyclooxygenase (COX)-2 expression and cell growth in human skin squamous carcinoma cells. Cancer Lett 161: 177–183, 2000

    Google Scholar 

  52. Chen LC, Sly L, De Luca LM: High dietary retinoic acid prevents malignant conversion of skin papillomas induced by a two-stage carcinogenesis protocol in female SENCAR mice. Carcinogenesis 15: 2383–2386, 1994

    Google Scholar 

  53. Jurukovski V, Simon M: Epidermal growth factor signaling pathway influences retinoid metabolism by reduction of retinyl ester hydrolase activities in normal and malignant keratinocytes. J Cell Physiol 183: 265–272, 2000

    Google Scholar 

  54. Thompson KL, Rosner MR: Regulation of epidermal growth factor receptor gene expression by retinoic acid and epidermal growth factor. J Biol Chem 264: 3230–3234, 1989

    Google Scholar 

  55. Lippman SM, Kalvakolanu DV, Lotan R: Retinoids and interferons in non-melanoma skin cancer. J Investig Dermatol Symp Proc 1: 219–222, 1996

    Google Scholar 

  56. Levine N: Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 39: 62–66, 1998

    Google Scholar 

  57. Katsambas AD, Katoulis AC: Topical retinoids in the treatment of aging of the skin. Adv Exp Med Biol 455: 477–482, 1999

    Google Scholar 

  58. DiGiovanna JJ: Retinoid chemoprevention in patients at high risk for skin cancer. Med Pediatr Oncol 36: 564–567, 2001

    Google Scholar 

  59. Cassady JM, Baird WM, Chang CJ: Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents. J Nat Prod 53: 23–41, 1990

    Google Scholar 

  60. Keller KL, Fenske NA: Uses of vitamins A, C, and E and related compounds in dermatology: A review. J Am Acad Dermatol 39: 611–625, 1998

    Google Scholar 

  61. Savoure N, Briand G, Amory-Touz MC, Combre A, Maudet M, Nicol M: Vitamin A status and metabolism of cutaneous polyamines in the hairless mouse after UV irradiation: Action of beta-carotene and astaxanthin. Int J Vitam Nutr Res 65: 79–86, 1995

    Google Scholar 

  62. Katsumura N, Okuno M, Onogi N, Moriwaki H, Muto Y, Kojima S: Suppression of mouse skin papilloma by canthaxanthin and beta-carotene in vivo: Possibility of the regression of tumorigenesis by carotenoids without conversion to retinoic acid. Nutr Cancer 26: 203–208, 1996

    Google Scholar 

  63. Chen LC, Sly L, Jones CS, Tarone R, De Luca LM: Differential effects of dietary beta-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin. Carcinogenesis 14: 713–717, 1993

    Google Scholar 

  64. Biesalski HK, Obermueller-Jevic UC: UV light, beta-carotene and human skin – beneficial and potentially harmful effects. Arch Biochem Biophys 389: 1–6, 2001

    Google Scholar 

  65. Pauling L: Effect of ascorbic acid on incidence of spontaneous mammary tumors andUV-light-induced skin tumors in mice. Am J Clin Nutr 54: 1252S–1255S, 1991

    Google Scholar 

  66. Bissett DL, Chatterjee R, Hannon DP: Photoprotective effect of superoxide-scavenging antioxidants against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed 7: 56–62, 1990

    Google Scholar 

  67. Smart RC, Crawford CL: Effect of ascorbic acid and its synthetic lipophilic derivative ascorbyl palmitate on phorbol ester-induced skin-tumor promotion in mice. Am J Clin Nutr 54: 1266S–1273S, 1991

    Google Scholar 

  68. Smart RC, Huang MT, Han ZT, Kaplan MC, Focella A, Conney AH: Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate. Cancer Res 47: 6633–6638, 1987

    Google Scholar 

  69. Dreher F, Maibach H: Protective effects of topical antioxidants in humans. Curr Probl Dermatol 29: 157–164, 2001

    Google Scholar 

  70. Kalka K, Mukhtar H, Turowski-Wanke A, Merk H: Biomelanin antioxidants in cosmetics: Assessment based on inhibition of lipid peroxidation. Skin Pharmacol Appl Skin Physiol 13: 143–149, 2000

    Google Scholar 

  71. Burke KE, Clive J, Combs GF Jr, Commisso J, Keen CL, Nakamura RM: Effects of topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh:2 hairless mice. Nutr Cancer 38: 87–97, 2000

    Google Scholar 

  72. Budiyanto A, Ahmed NU, Wu A, Bito T, Nikaido O, Osawa T, Ueda M, Ichihashi M: Protective effect of topically applied olive oil against photocarcinogenesis following UVB exposure of mice. Carcinogenesis 21: 2085–2090, 2000

    Google Scholar 

  73. Ichihashi M, Ahmed NU, Budiyanto A, Wu A, Bito T, Ueda M, Osawa T: Preventive effect of antioxidant on ultraviolet-induced skin cancer in mice. J Dermatol Sci. 23: S45–S50, 2000

    Google Scholar 

  74. Perchellet JP, Abney NL, Thomas RM, Guislain YL, Perchellet EM: Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin. Cancer Res 47: 477–485, 1987

    Google Scholar 

  75. Chen W, Barthelman M, Martinez J, Alberts D, Gensler HL: Inhibition of cyclobutane pyrimidine dimer formation in epidermal p53 gene of UV-irradiated mice by alpha-tocopherol. Nutr Cancer 29: 205–211, 1997

    Google Scholar 

  76. McVean M, Liebler DC: Prevention of DNA photodamage by vitamin E compounds and sunscreens: Roles of ultraviolet absorbance and cellular uptake. Mol Carcinog 24: 169–176, 1999

    Google Scholar 

  77. Alberts DS, Goldman R, Xu MJ, Dorr RT, Quinn J, Welch K, Guillen-Rodriguez J, Aickin M, Peng YM, Loescher L, Gensler H: Disposition and metabolism of topically administered alpha-tocopherol acetate: A common ingredient of commercially available sunscreens and cosmetics. Nutr Cancer 26: 193–201, 1996

    Google Scholar 

  78. Majewski S, Kutner A, Jablonska S: Vitamin D analogs in cutaneous malignancies. Curr Pharm Des 6: 829–838, 2000

    Google Scholar 

  79. van De Kerkhof PC: New developments in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 14: 129–135, 2001

    Google Scholar 

  80. Reichrath J: Will analogs of 1,25-dihydroxyvitamin D(3) (calcitriol) open a new era in cancer therapy? Onkologie 24: 128–133, 2001

    Google Scholar 

  81. Carlberg C, Saurat JH: Vitamin D-retinoid association: Molecular basis and clinical applications. J Investig Dermatol Symp Proc 1: 82–86, 1996

    Google Scholar 

  82. Brown KM, Arthur JR: Selenium, selenoproteins and human health: A review. Public Health Nutr 4: 593–599, 2001

    Google Scholar 

  83. El-Bayoumy K: The protective role of selenium on genetic damage and on cancer. Mutat Res 475: 123–139, 2001

    Google Scholar 

  84. Dhur A, Galan P, Hercberg S: Relationship between selenium, immunity and resistance against infection. Comp Biochem Physiol 96: 271–280, 1990

    Google Scholar 

  85. Lanfear J, Fleming J, Wu L, Webster G, Harrison PR: The selenium metabolite selenodiglutathione induces p53 and apoptosis: Relevance to the chemopreventive effects of selenium? Carcinogenesis 15: 1387–1392, 1994

    Google Scholar 

  86. Ghose A, Fleming J, El-Bayoumy K, Harrison PR: Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: Involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res 61: 7479–7487, 2001

    Google Scholar 

  87. Overvad K, Thorling EB, Bjerring P, Ebbesen P: Selenium inhibits UV-light-induced skin carcinogenesis in hairless mice. Cancer Lett 27: 163–170, 1985

    Google Scholar 

  88. Bansal MP, Gupta G: Influence of selenium on 3-methylcholanthrene induced skin carcinogenesis in mice. J Environ Pathol Toxicol Oncol 8: 49–53, 1988

    Google Scholar 

  89. Burke KE, Burford RG, Combs GF Jr, French IW, Skeffington DR: The effect of topical L-selenomethionine on minimal erythema dose of ultraviolet irradiation in humans. Photodermatol Photoimmunol Photomed 9: 52–57, 1992

    Google Scholar 

  90. McKenzie RC: Selenium, ultraviolet radiation and the skin. Clin Exp Dermatol 25: 631–636, 2000

    Google Scholar 

  91. Steenvoorden DP, Hasselbaink DM, Beijersbergen van Henegouwen GM: Protection against UV-induced reactive intermediates in human cells and mouse skin by glutathione precursors: A comparison of N-acetylcysteine and glutathione ethylester. Photochem Photobiol 67: 651–656, 1998

    Google Scholar 

  92. Thiele JJ, Schroeter C, Hsieh SN, Podda M, Packer L: The antioxidant network of the stratum corneum. Curr Probl Dermatol 29: 26–42, 2001

    Google Scholar 

  93. Afaq F, Mukhtar H: Effects of solar radiation on cutaneous detoxification pathways. J Photochem Photobiol B 63: 61–69, 2001

    Google Scholar 

  94. Perchellet JP, Perchellet EM, Orten DK, Schneider BA: Inhibition of the effects of 12-O-tetradecanoylphorbol-13-acetate on mouse epidermal glutathione peroxidase and ornithine decarboxylase activities by glutathione level-raising agents and selenium-containing compounds. Cancer Lett 26: 283–293, 1985

    Google Scholar 

  95. Perchellet JP, Owen MD, Posey TD, Orten DK, Schneider BA: Inhibitory effects of glutathione level-raising agents and D-alpha-tocopherol on ornithine decarboxylase induction and mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 6: 567–573, 1985

    Google Scholar 

  96. Jones SA, McArdle F, Jack CI, Jackson MJ: Effect of antioxidant supplementation on the adaptive response of human skin fibroblasts to UV-induced oxidative stress. Redox Rep 4: 291–299, 1999

    Google Scholar 

  97. Moysan A, Marquis I, Gaboriau F, Santus R, Dubertret L, Morliere P: Ultraviolet A-induced lipid peroxidation and antioxidant defense systems in cultured human skin fibroblasts. J Invest Dermatol 100: 692–698, 1993

    Google Scholar 

  98. Weeks CE, Herrmann AL, Nelson FR, Slaga TJ: alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc Natl Acad Sci USA 79: 6028–6032, 1982

    Google Scholar 

  99. Mitsunaga S, Clapper M, Litwin S, Watts P, Bauer B, Klein-Szanto AJ: Chemopreventive effect of difluoromethylornithine (DFMO) on mouse skin squamous cell carcinomas induced by benzo(a)pyrene. J Cell Biochem 28–29(Suppl): 81–89, 1997

    Google Scholar 

  100. Fischer SM, Lee M, Lubet RA: Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice. Carcinogenesis 22: 83–88, 2001

    Google Scholar 

  101. Lan L, Trempus C, Gilmour SK: Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice. Cancer Res 60: 5696–5703, 2000

    Google Scholar 

  102. Arbeit JM, Riley RR, Huey B, Porter C, Kelloff G, Lubet R, Ward JM, Pinkel D: Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Cancer Res 59: 3610–3620, 1999

    Google Scholar 

  103. Ahmad N, Gilliam AC, Katiyar SK, O'Brien TG, Mukhtar H: A definitive role of ornithine decarboxylase in photocarcinogenesis. Am J Pathol 159: 885–892, 2001

    Google Scholar 

  104. Alberts DS, Dorr RT, Einspahr JG, Aickin M, Saboda K, Xu MJ, Peng YM, Goldman R, Foote JA, Warneke JA, Salasche S, Roe DJ, Bowden GT: Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol Biomarkers Prev 9: 1281–1286, 2000

    Google Scholar 

  105. Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM: Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat 62: 367–384, 2000

    Google Scholar 

  106. Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R: Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20: 1939–1944, 1999

    Google Scholar 

  107. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 25: 231–240, 1999

    Google Scholar 

  108. Muller-Decker K, Kopp-Schneider A, Marks F, Seibert K, Furstenberger G: Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2. Mol Carcinog 23: 36–44, 1998

    Google Scholar 

  109. Kochevar IE, Moran M, Lyon N, Flotte T, Siebert E, Gange RW: Effects of systemic indomethacin, meclizine, and BW755C on chronic ultraviolet B-induced effects in hairless mouse skin. J Invest Dermatol 100: 186–193, 1993

    Google Scholar 

  110. Jiang H, Yamamoto S, Kato R: Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor. Carcinogenesis 15: 807–812, 1994

  111. Jiang H, Yamamoto S, Ozawa S, Shimada M, Yamazoe Y, Kato R: Inhibitory effect of TMK688 on skin tumor initiation caused by 7,12-dimethylbenz[a]anthracene in relation to inhibition of aryl hydrocarbon hydroxylase activity and Cyp1a1 mRNA induction. Pharmacology 53: 123–132, 1996

    Google Scholar 

  112. Hong WK, Sporn MB: Recent advances in chemoprevention of cancer. Science 278: 1073–1077, 1997

    Google Scholar 

  113. Ahmad N, Mukhtar H: Cutaneous photochemoprotection by green tea: A brief review. Skin Pharmacol Appl Skin Physiol 14: 69–76, 2001

    Google Scholar 

  114. Ahmad N, Katiyar SK, Mukhtar H: Antioxidants in chemoprevention of skin cancer. Curr Probl Dermatol 29: 128–139, 2001

    Google Scholar 

  115. Katiyar SK, Mukhtar H: Tea antioxidants in cancer chemoprevention. J Cell Biochem 27(Suppl): 59–67, 1997

    Google Scholar 

  116. Singletary K: Diet, natural products and cancer chemoprevention. J Nutr 130: 465S–466S, 2000

    Google Scholar 

  117. Stratton SP, Dorr RT, Alberts DS: The state-of-the-art in chemoprevention of skin cancer. Eur J Cancer 36: 1292–1297, 2000

    Google Scholar 

  118. Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB: The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22: 375–383, 1995

    Google Scholar 

  119. Khan WA, Wang ZY, Athar M, Bickers DR, Mukhtar H: Inhibition of the skin tumorigenicity of (+/—)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Lett 42: 7–12, 1988

    Google Scholar 

  120. Wang ZY, Agarwal R, Bickers DR, Mukhtar H: Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 12: 1527–1530, 1991

    Google Scholar 

  121. Conney AH, Wang ZY, Huang MT, Ho CT, Yang CS: Inhibitory effect of green tea on tumorigenesis by chemicals and ultraviolet light. Prev Med 21: 361–369, 1992

    Google Scholar 

  122. Katiyar SK, Agarwal R, Mukhtar H: Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea. Cancer Res 53: 5409–5412, 1993

    Google Scholar 

  123. Wang ZY, Huang MT, Ho CT, Chang R, Ma W, Ferraro T, Reuhl KR, Yang CS, Conney AH: Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 52: 6657–6665, 1992

    Google Scholar 

  124. Agarwal R, Katiyar SK, Zaidi SI, Mukhtar H: Inhibition of skin tumor promoter-caused induction of epidermal ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives. Cancer Res 52: 3582–3588, 1992

    Google Scholar 

  125. Katiyar SK, Mukhtar H: Green tea polyphenol (—)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol 69: 719–726, 2001

    Google Scholar 

  126. Record IR, Dreosti IE: Protection by black tea and green tea against UVB and UVA+B induced skin cancer in hairless mice. Mutat Res 422: 191–199, 1998

    Google Scholar 

  127. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H: Inhibition of uvb-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (—)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 176: 110–117, 2001

    Google Scholar 

  128. Kim J, Hwang JS, Cho YK, Han Y, Jeon YJ, Yang KH: Protective effects of (—)-epigallocatechin-3-gallate on UVA-and UVB-induced skin damage. Skin Pharmacol Appl Skin Physiol 14: 11–19, 2001

    Google Scholar 

  129. Agarwal R, Katiyar SK, Khan SG, Mukhtar H: Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea. Photochem Photobiol 58: 695–700, 1993

    Google Scholar 

  130. Katiyar SK, Elmets CA, Agarwal R, Mukhtar H: Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol 62: 855–861, 1995

    Google Scholar 

  131. Lu YP, Lou YR, Li XH, Xie JG, Brash D, Huang MT, Conney AH: Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1mice. Cancer Res 60: 4785–4791, 2000

    Google Scholar 

  132. Liu Q, Wang Y, Crist KA, Wang ZY, Lou YR, Huang MT, Conney AH, You M: Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors. Carcinogenesis 19: 1257–1262, 1998

    Google Scholar 

  133. Katiyar SK, Rupp CO, Korman NJ, Agarwal R, Mukhtar H: Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1 alpha mRNA and protein expression in SENCAR mice by green tea polyphenols. J Invest Dermatol 105: 394–398, 1995

    Google Scholar 

  134. Katiyar SK, Challa A, McCormick TS, Cooper KD, Mukhtar H: Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (—)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 20: 2117–2124, 1999

    Google Scholar 

  135. Halliday GM, Bestak R, Yuen KS, Cavanagh LL, Barnetson RS: UVA-induced immunosuppression. Mutat Res 422: 139–145, 1998

    Google Scholar 

  136. Katiyar SK, Matsui MS, Elmets CA, Mukhtar H: Polyphenolic antioxidant (—)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol 69: 148–153, 1999

    Google Scholar 

  137. Katiyar SK, Perez A, Mukhtar H: Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Clin Cancer Res 6: 3864–3869, 2000

    Google Scholar 

  138. Katiyar SK, Afaq F, Perez A, Mukhtar H: Green tea polyphenol (—)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22: 287–294, 2001

    Google Scholar 

  139. Katiyar SK, Agarwal R, Mukhtar H: Inhibition of both stage I and stage II skin tumor promotion in SENCAR mice by a polyphenolic fraction isolated from green tea: Inhibition depends on the duration of polyphenol treatment. Carcinogenesis 14: 2641–2643, 1993

    Google Scholar 

  140. Katiyar SK, Agarwal R, Mukhtar H: Inhibition of spontaneous and photo-enhanced lipid peroxidation in mouse epidermal microsomes by epicatechin derivatives from green tea. Cancer Lett 79: 61–66, 1994

    Google Scholar 

  141. Katiyar SK, Mohan RR, Agarwal R, Mukhtar H: Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols. Carcinogenesis 18: 497–502, 1997

    Google Scholar 

  142. Jang M, Pezzuto JM: Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res 25: 65–77, 1999

    Google Scholar 

  143. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218–220, 1997

    Google Scholar 

  144. Jang M, Pezzuto JM: Effects of resveratrol on 12-Otetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett 134: 81–89, 1998

    Google Scholar 

  145. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H: Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7: 1466–1473, 2001

    Google Scholar 

  146. Adhami VM, Afaq F, Ahmad N: Involvement of the retinoblastoma (prb)-e2f/dp pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (a431) cells. Biochem Biophys Res Commun 288: 579–585, 2001

    Google Scholar 

  147. She QB, Bode AM, Ma WY, Chen NY, Dong Z: Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61: 1604–1610, 2001

    Google Scholar 

  148. Katiyar SK, Agarwal R, Mukhtar H: Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res 56: 1023–1030, 1996

    Google Scholar 

  149. Park KK, Chun KS, Lee JM, Lee SS, Surh YJ: Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 129: 139–144, 1998

    Google Scholar 

  150. Bode AM, Ma WY, Surh YJ, Dong Z: Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 61: 850–853, 2001

    Google Scholar 

  151. Azuine MA, Bhide SV: Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17: 77–83, 1992

    Google Scholar 

  152. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, Huang MT: Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 31: 385–396, 1991

    Google Scholar 

  153. Huang MT, Wang ZY, Georgiadis CA, Laskin JD, Conney AH: Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 13: 2183–2186, 1992

    Google Scholar 

  154. Limtrakul P, Lipigorngoson S, Namwong O, Apisariyaku A, Dunn FW: Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116: 197–203, 1997

    Google Scholar 

  155. Nakamura Y, Ohto Y, Murakami A, Osawa T, Ohigashi H: Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor promoter-induced reactive oxygen species generation in leukocytes in vitro and in vivo. Jpn J Cancer Res 89: 361–370, 1998

    Google Scholar 

  156. Lu YP, Chang RL, Huang MT, Conney AH: Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14: 293–297, 1993

    Google Scholar 

  157. Huang MT, Smart RC, Wong CQ, Conney AH: Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48: 5941–5946, 1988

    Google Scholar 

  158. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51: 813–819, 1991

    Google Scholar 

  159. Shah RG, Netrawali MS: Evaluation of mutagenic activity of turmeric extract containing curcumin, before and after activation with mammalian cecal microbial extract of liver microsomal fraction, in the Ames Salmonella test. Bull Environ Contam Toxicol 40: 350–357, 1988

    Google Scholar 

  160. Iersel ML, Ploemen JP, Struik I, van Amersfoort C, Keyzer AE, Schefferlie JG, van Bladeren PJ: Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal. Chem Biol Interact 102: 117–132, 1996

    Google Scholar 

  161. Ishizaki C, Oguro T, Yoshida T, Wen CQ, Sueki H, Iijima M: Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-otetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dermatology 193: 311–317, 1996

    Google Scholar 

  162. Kuttan R, Sudheeran PC, Josph CD: Turmeric and curcumin as topical agents in cancer therapy. Tumori 73: 29–31, 1987

    Google Scholar 

  163. Jee SH, Shen SC, Tseng CR, Chiu HC, Kuo ML: Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 111: 656–661, 1998

    Google Scholar 

  164. Perchellet JP, Perchellet EM, Abney NL, Zirnstein JA, Belman S: Effects of garlic and onion oils on glutathione peroxidase activity, the ratio of reduced/oxidized glutathione and ornithine decarboxylase induction in isolated mouse epidermal cells treated with tumor promoters. Cancer Biochem Biophys 8: 299–312, 1986

    Google Scholar 

  165. Sadhana AS, Rao AR, Kucheria K, Bijani V: Inhibitory action of garlic oil on the initiation of benzo[a]pyrene-induced skin carcinogenesis in mice. Cancer Lett 40: 193–197, 1988

    Google Scholar 

  166. Perchellet JP, Perchellet EM, Belman S: Inhibition of DMBA-induced mouse skin tumorigenesis by garlic oil and inhibition of two tumor-promotion stages by garlic and onion oils. Nutr Cancer 14: 183–193, 1990

    Google Scholar 

  167. Athar M, Raza H, Bickers DR, Mukhtar H: Inhibition of benzoyl peroxide-mediated tumor promotion in 7,12-dimethylbenz(a)anthracene-initiated skin of Sencar mice by antioxidants nordihydroguaiaretic acid and diallyl sulfide. J Invest Dermatol 94: 162–165, 1990

    Google Scholar 

  168. Dwivedi C, Rohlfs S, Jarvis D, Engineer FN: Chemoprevention of chemically induced skin tumor development by diallyl sulfide and diallyl disulfide. Pharm Res 9: 1668–1670, 1992

    Google Scholar 

  169. Singh A, Shukla Y: Antitumor activity of diallyl sulfide in two-stage mouse skin model of carcinogenesis. Biomed Environ Sci 11: 258–263, 1998

    Google Scholar 

  170. Singh A, Shukla Y: Antitumour activity of diallyl sulfide on polycyclic aromatic hydrocarbon-induced mouse skin carcinogenesis. Cancer Lett 131: 209–214, 1998

    Google Scholar 

  171. Agarwal R, Katiyar SK, Lundgren DW, Mukhtar H: Inhibitory effect of silymarin, an anti-hepatotoxic flavonoid, on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and mRNA in SENCAR mice. Carcinogenesis 15: 1099–1103, 1994

    Google Scholar 

  172. Katiyar SK, Korman NJ, Mukhtar H, Agarwal R: Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst 89: 556–566, 1997

    Google Scholar 

  173. Chatterjee ML, Agarwal R, Mukhtar H: Ultraviolet B radiation-induced DNA lesions in mouse epidermis: An assessment using a novel 32P-postlabelling technique. Biochem Biophys Res Commun 229: 590–595, 1996

    Google Scholar 

  174. Zhao J, Sharma Y, Agarwal R: Significant inhibition by the flavonoid antioxidant silymarin against 12-Otetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotion. Mol Carcinog 26: 321–333, 1999

    Google Scholar 

  175. Zhao J, Lahiri-Chatterjee M, Sharma Y, Agarwal R: Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis 21: 811–816, 2000

    Google Scholar 

  176. Saliou C, Kitazawa M, McLaughlin L, Yang JP, Lodge JK, Tetsuka T, Iwasaki K, Cillard J, Okamoto T, Packer L: Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line. Free Radic Biol Med 26: 174–183, 1999

    Google Scholar 

  177. Wei H, Wei L, Frenkel K, Bowen R, Barnes S: Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20: 1–12, 1993

    Google Scholar 

  178. Wei H, Bowen R, Cai Q, Barnes S, Wang Y: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208: 124–130, 1995

    Google Scholar 

  179. Wei H, Bowen R, Zhang X, Lebwohl M: Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis 19: 1509–1514, 1998

    Google Scholar 

  180. Miller CC, Hale P, Pentland AP: Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation. J Biol Chem 269: 3529–3533, 1994

    Google Scholar 

  181. Cai Q, Wei H: Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 25: 1–7, 1996

    Google Scholar 

  182. Wang Y, Zhang X, Lebwohl M, DeLeo V, Wei H: Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis 19: 649–654, 1998

    Google Scholar 

  183. Birt DF, Walker B, Tibbels MG, Bresnick E: Antimutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis 7: 959–963, 1986

    Google Scholar 

  184. Birt DF, Mitchell D, Gold B, Pour P, Pinch HC: Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 17: 85–91, 1997

    Google Scholar 

  185. Wei H, Tye L, Bresnick E, Birt DF: Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50: 499–502, 1990

    Google Scholar 

  186. Lin JK, Chen YC, Huang YT, Lin-Shiau SY: Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J Cell Biochem 28–29(Suppl): 39–48, 1997

    Google Scholar 

  187. Lepley DM, Pelling JC: Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19: 74–82, 1997

    Google Scholar 

  188. Lepley DM, Li B, Birt DF, Pelling JC. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367–2375, 1996

    Google Scholar 

  189. McVean M, Xiao H, Isobe K, Pelling JC: Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 21: 633–639, 2000

    Google Scholar 

  190. Shore RE: Radiation-induced skin cancer in humans. Med Pediatr Oncol 36: 549–554, 2001

    Google Scholar 

  191. American Cancer Society-Cancer Facts and Figures: Graphical Data (available at the web site http://www.cancer.org)

  192. Mukhtar H, Ahmad N: Cancer chemoprevention: Future holds in multiple agents. Toxicol Appl Pharmacol 158: 207–210, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Case Western Reserve University & The Research Institute of University Hospitals of Cleveland, Cleveland, OH

    Sanjay Gupta

  2. Department of Dermatology, University of Wisconsin, Madison, WI, USA

    Hasan Mukhtar

Authors
  1. Sanjay Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hasan Mukhtar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, S., Mukhtar, H. Chemoprevention of Skin Cancer: Current Status and Future Prospects. Cancer Metastasis Rev 21, 363–380 (2002). https://doi.org/10.1023/A:1021275330385

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021275330385

Search

Navigation